Literature DB >> 2935541

The fibronectin receptor on mammalian erythroid precursor cells: characterization and developmental regulation.

V P Patel, H F Lodish.   

Abstract

The plasma membrane of murine erythro-leukemia (MEL) cells contains a 140-kD protein that binds specifically to fibronectin. A 125I-labeled 140-kD protein from surface-labeled uninduced MEL cells was specifically bound by an affinity matrix that contained the 115-kD cell binding fragment of fibronectin, and specifically eluted by a synthetic peptide that has cell attachment-promoting activity. The loss of this protein during erythroid differentiation was correlated with loss of cellular adhesion to fibronectin. Both MEL cells and reticulocytes attached to the same site on fibronectin as do fibroblasts since adhesion of erythroid cells to fibronectin was specifically blocked by a monoclonal antibody directed against the cell-binding fragment of fibronectin and by a synthetic peptide containing the Arg-Gly-Asp-Ser sequence found in the cell-binding fragment of fibronectin. Erythroid cells attached specifically to surfaces coated either with the 115-kD cell-binding fragment of fibronectin or with the synthetic peptide-albumin complex. Thus, the erythroid 140-kD protein exhibits several properties in common with those described for the fibronectin receptor of fibroblasts. We propose that loss or modification of this protein at the cell surface is responsible for the loss of cellular adhesion to fibronectin during erythroid differentiation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2935541      PMCID: PMC2114070          DOI: 10.1083/jcb.102.2.449

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  48 in total

1.  Biogenesis of erythrocyte membrane proteins. In vivo studies in anemic rabbits.

Authors:  P A Koch; J E Gartrell; F H Gardner; J R Carter
Journal:  Biochim Biophys Acta       Date:  1975-04-21

2.  Asynchronous synthesis of erythrocyte membrane proteins.

Authors:  H Chang; P J Langer; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

3.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.

Authors:  E Engvall; E Ruoslahti
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

Review 4.  Cellular adhesiveness and extracellular substrata.

Authors:  F Grinnell
Journal:  Int Rev Cytol       Date:  1978

5.  Attachment and spreading of baby hamster kidney cells to collagen substrata: effects of cold-insoluble globulin.

Authors:  F Grinnell; D Minter
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

6.  Expression of the major red cell sialoglycoprotein, glycophorin A, in the human leukemic cell line K562.

Authors:  C G Gahmberg; M Jokinen; L C Andersson
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Molecular changes in the membranes of mouse erythroid cells accompanying differentiation.

Authors:  J B Geiduschek; S J Singer
Journal:  Cell       Date:  1979-01       Impact factor: 41.582

9.  Cross-linking of fibronectin to sulfated proteoglycans at the cell surface.

Authors:  M E Perkins; T H Ji; R O Hynes
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

10.  Enzymatic iodination of Sindbis virus proteins.

Authors:  B M Sefton; G G Wickus; B W Burge
Journal:  J Virol       Date:  1973-05       Impact factor: 5.103

View more
  35 in total

1.  1,25-Dihydroxyvitamin D3 induces collagen binding to the human monocyte line U937.

Authors:  B S Polla; A M Healy; M Byrne; S M Krane
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Human colon carcinoma cells use multiple receptors to adhere to laminin: involvement of alpha 6 beta 4 and alpha 2 beta 1 integrins.

Authors:  M M Lotz; C A Korzelius; A M Mercurio
Journal:  Cell Regul       Date:  1990-02

3.  Structure and transcription of the mouse erythropoietin receptor gene.

Authors:  H Youssoufian; L I Zon; S H Orkin; A D D'Andrea; H F Lodish
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

4.  Temporal, spatial, and phenotypical changes of PDGFRα expressing fibroblasts during late lung development.

Authors:  Mehari Endale; Shawn Ahlfeld; Erik Bao; Xiaoting Chen; Jenna Green; Zach Bess; Matthew T Weirauch; Yan Xu; Anne Karina Perl
Journal:  Dev Biol       Date:  2017-04-11       Impact factor: 3.582

5.  Developmentally regulated expression of a 78 kDa erythroblast membrane glycoprotein immunologically related to the platelet thrombospondin receptor.

Authors:  N Kieffer; A Bettaieb; C Legrand; L Coulombel; W Vainchenker; L Edelman; J Breton-Gorius
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

6.  Wheat-germ-agglutinin and Ricinus communis-agglutinin-binding sites of BHK cells compared with each other and with 140 kDa fibronectin receptors.

Authors:  T L Tuan; F Grinnell
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

Review 7.  The extracellular matrix of the hematopoietic microenvironment.

Authors:  G Klein
Journal:  Experientia       Date:  1995-09-29

8.  Differentiation-associated switches in protein 4.1 expression. Synthesis of multiple structural isoforms during normal human erythropoiesis.

Authors:  J A Chasis; L Coulombel; J Conboy; S McGee; K Andrews; Y W Kan; N Mohandas
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

9.  Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors.

Authors:  T Moritz; V P Patel; D A Williams
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

10.  B lymphocytes express and lose syndecan at specific stages of differentiation.

Authors:  R D Sanderson; P Lalor; M Bernfield
Journal:  Cell Regul       Date:  1989-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.